Kamoun S, Hammami A, Ben Hamed S, Sahnoun M M, Elleuch F, Daoud M
Service de cardiologie, faculté de médecine, CHU Hédi-Chaker de Sfax, Tunisie.
Arch Mal Coeur Vaiss. 1991 Feb;84(2):269-71.
The authors report the case of a 22 year old patient with brucella endocarditis on a Starr-Edwards aortic valve prosthesis implanted 5 years previously. Six blood cultures were positive for Brucella melitensis biovar I. Antibiotic therapy associating Rifampicin and Tetracycline and then Rifampicin and Ofloxacine did not prevent abscess formation and valve dehiscence. The poor haemodynamic status and persistent infection led to replacement of the valve prosthesis. Culture of the infected prosthesis grew a colony of brucella melitensis resistant to fluoro-quinolones. Valve replacement and antibiotic therapy led to clinical improvement and constant apyrexia with a 12 month follow-up. Brucella endocarditis on a valve prosthesis is a very rare occurrence. The combination of valve replacement and antibiotic therapy is usually required.
作者报告了一例22岁患者的病例,该患者在5年前植入的Starr-Edwards主动脉瓣人工瓣膜上发生了布鲁氏菌性心内膜炎。六次血培养均显示马尔他布鲁氏菌生物变种I阳性。联合使用利福平与四环素以及之后联合使用利福平与氧氟沙星的抗生素治疗未能预防脓肿形成和瓣膜裂开。血流动力学状态不佳和持续感染导致了瓣膜假体的置换。感染的假体培养物长出了一株对氟喹诺酮耐药的马尔他布鲁氏菌菌落。瓣膜置换和抗生素治疗使患者临床症状改善,持续无发热,随访12个月。人工瓣膜上的布鲁氏菌性心内膜炎非常罕见。通常需要联合进行瓣膜置换和抗生素治疗。